| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |